Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246959 · ClinicalTrials.gov registry record · NA
Process Versus Outcomes Incentives for Lipid Management
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 764
- Enrollment target
NCT02246959: Completed NA study, sponsored by University of Pennsylvania.
NCT02246959 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 764 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02246959, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 764 participants
- Enrollment target
Study Summary
In a 4-arm, randomized controlled trial, we will evaluate the relative effectiveness and cost-effectiveness of improving cholesterol levels among participants who are at high risk of CVD and who have elevated LDL cholesterol levels by testing process versus outcomes financial incentives. Participants will use electronic pill bottles that continuously monitor statin adherence. The primary outcome will be change in LDL cholesterol over 12 months.
Interventions
- BEHAVIORAL Process Incentive
- BEHAVIORAL Outcome Incentive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 764 participants |
| Start Date | 2015-02 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02246959 record still lists
NCT02246959 is an interventional study that assigns participants to a tested intervention. The registered 764 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 2 interventions - of which Process Incentive is the first listed.
NCT02246959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02246959 about?
NCT02246959 is a clinical study titled "Process Versus Outcomes Incentives for Lipid Management". In a 4-arm, randomized controlled trial, we will evaluate the relative effectiveness and cost-effectiveness of improving cholesterol levels among participants who are at high risk of CVD and who have elevated LDL cholesterol levels by testing process versus outcomes financial incentives. Participant...
What is the current status of trial NCT02246959?
This trial is currently completed. It is a NA study. The enrollment target is 764 participants. The study started on 2015-02. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02246959?
The interventions under investigation include: Process Incentive (BEHAVIORAL), Outcome Incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT02246959?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02246959's enrollment target sits among peer trials
764 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578665 · 764 participants · NA
Human-like Robotic Controllers for Enhanced Motor Learning
- NCT05579366 · 764 participants · Phase 1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- NCT03789552 · 765 participants · Phase 3
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
- NCT07195591 · 766 participants · Phase 3
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia